Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jens Goebel

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
Transplantation Reviews (Orlando, Fla.)|April 2, 2011
Pediatric aspects of therapeutic drug monitoring of mycophenolic acid in renal transplantationBurkhard Tönshoff, Elias David-Neto, Robert Ettenger, et al.
Transplantation|February 20, 2016
The Noninvasive Urinary Polyomavirus Haufen Test Predicts BK Virus Nephropathy in Children After Hematopoietic Cell Transplantation: A Pilot StudyBenjamin L Laskin, Harsharan K Singh, Ulf H Beier, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 10, 2011
Blood, and not urine, BK viral load predicts renal outcome in children with hemorrhagic cystitis following hematopoietic stem cell transplantationHilary L Haines, Benjamin L Laskin, Jens Goebel, et al.
Pediatric Nephrology (Berlin, Germany)|April 12, 2018
COQ2 nephropathy: a treatable cause of nephrotic syndrome in childrenMichelle C Starr, Irene J Chang, Laura S Finn, et al.
Blood|May 31, 2014
Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adultsSonata Jodele, Stella M Davies, Adam Lane, et al.
Transplantation|December 1, 2017
Analysis of Biomarkers Within the Initial 2 Years Posttransplant and 5-Year Kidney Transplant Outcomes: Results From Clinical Trials in Organ Transplantation-17Geovani Faddoul, Girish N Nadkarni, Nancy D Bridges, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 13, 2015
Variable Eculizumab Clearance Requires Pharmacodynamic Monitoring to Optimize Therapy for Thrombotic Microangiopathy after Hematopoietic Stem Cell TransplantationSonata Jodele, Tsuyoshi Fukuda, Kana Mizuno, et al.
Pediatric Transplantation|September 5, 2017
Mycophenolate mofetil-related leukopenia in children and young adults following kidney transplantation: Influence of genes and drugsCharles D Varnell, Tsuyoshi Fukuda, Cassie L Kirby, et al.
Health and Quality of Life Outcomes|August 25, 2017
Responsiveness of the PROMIS® measures to changes in disease status among pediatric nephrotic syndrome patients: a Midwest pediatric nephrology consortium studyDavid T Selewski, Jonathan P Troost, Danyelle Cummings, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 16, 2021
COVID-19 in pediatric kidney transplantation: The Improving Renal Outcomes CollaborativeCharles Varnell, Lyndsay A Harshman, Laurie Smith, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
Transplantation Reviews (Orlando, Fla.)|April 2, 2011
Pediatric aspects of therapeutic drug monitoring of mycophenolic acid in renal transplantationBurkhard Tönshoff, Elias David-Neto, Robert Ettenger, et al.
Transplantation|February 20, 2016
The Noninvasive Urinary Polyomavirus Haufen Test Predicts BK Virus Nephropathy in Children After Hematopoietic Cell Transplantation: A Pilot StudyBenjamin L Laskin, Harsharan K Singh, Ulf H Beier, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 10, 2011
Blood, and not urine, BK viral load predicts renal outcome in children with hemorrhagic cystitis following hematopoietic stem cell transplantationHilary L Haines, Benjamin L Laskin, Jens Goebel, et al.
Pediatric Nephrology (Berlin, Germany)|April 12, 2018
COQ2 nephropathy: a treatable cause of nephrotic syndrome in childrenMichelle C Starr, Irene J Chang, Laura S Finn, et al.
Blood|May 31, 2014
Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adultsSonata Jodele, Stella M Davies, Adam Lane, et al.
Transplantation|December 1, 2017
Analysis of Biomarkers Within the Initial 2 Years Posttransplant and 5-Year Kidney Transplant Outcomes: Results From Clinical Trials in Organ Transplantation-17Geovani Faddoul, Girish N Nadkarni, Nancy D Bridges, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 13, 2015
Variable Eculizumab Clearance Requires Pharmacodynamic Monitoring to Optimize Therapy for Thrombotic Microangiopathy after Hematopoietic Stem Cell TransplantationSonata Jodele, Tsuyoshi Fukuda, Kana Mizuno, et al.
Pediatric Transplantation|September 5, 2017
Mycophenolate mofetil-related leukopenia in children and young adults following kidney transplantation: Influence of genes and drugsCharles D Varnell, Tsuyoshi Fukuda, Cassie L Kirby, et al.
Health and Quality of Life Outcomes|August 25, 2017
Responsiveness of the PROMIS® measures to changes in disease status among pediatric nephrotic syndrome patients: a Midwest pediatric nephrology consortium studyDavid T Selewski, Jonathan P Troost, Danyelle Cummings, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 16, 2021
COVID-19 in pediatric kidney transplantation: The Improving Renal Outcomes CollaborativeCharles Varnell, Lyndsay A Harshman, Laurie Smith, et al.
Pageof 9